BioNTech proposes KPMG as 2027 auditor
Rhea-AI Filing Summary
BioNTech SE (BNTX) announced that its Supervisory Board has approved the appointment of KPMG AG Wirtschaftsprüfungsgesellschaft as the company’s independent auditor for the financial year ending December 31, 2027, subject to election by shareholders at the upcoming Annual General Meeting.
The decision follows a comprehensive and competitive audit tender process overseen by the Audit Committee, which unanimously recommended KPMG. BioNTech states that, although it is not subject to mandatory auditor rotation requirements, periodically reassessing external audit arrangements through such processes is viewed as consistent with good governance practices.
Positive
- None.
Negative
- None.
Key Figures
Financial year covered by new audit appointment: Financial year ending December 31, 2027
Announcement date: September 18, 2026
2 metrics
Financial year covered by new audit appointment
Financial year ending December 31, 2027
Period for which KPMG is proposed as independent auditor
Announcement date
September 18, 2026
Date BioNTech announced Supervisory Board approval of KPMG’s appointment
Key Terms
independent auditor, Audit Committee, Annual General Meeting, mandatory auditor rotation requirements, +1 more
5 terms
independent auditor financial
"approved the appointment of KPMG as BioNTech’s independent auditor"
An independent auditor is an outside, qualified accounting professional or firm that examines a company's financial records and controls to determine whether its financial statements are accurate and prepared according to accepted accounting rules. Like a neutral referee or home inspector, the auditor issues a report that gives investors confidence (or raises red flags) about the reliability of the numbers, which affects assessments of risk, valuation and investment decisions.
Audit Committee financial
"audit tender process overseen by the Audit Committee of the Supervisory Board"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Annual General Meeting financial
"subject to election by the Company’s shareholders at the upcoming Annual General Meeting"
mandatory auditor rotation requirements regulatory
"BioNTech is not subject to mandatory auditor rotation requirements"
competitive audit tender process financial
"appointment follows a comprehensive and competitive audit tender process"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What auditor did BioNTech SE (BNTX) select for the 2027 financial year?
BioNTech’s Supervisory Board approved the appointment of KPMG AG Wirtschaftsprüfungsgesellschaft as the company’s independent auditor for the financial year ending December 31, 2027, subject to election by shareholders at the upcoming Annual General Meeting.
Is the KPMG auditor appointment for BioNTech (BNTX) already final?
No. The Supervisory Board has approved KPMG’s appointment as independent auditor for 2027, but it remains subject to election by shareholders at BioNTech’s upcoming Annual General Meeting.
How did BioNTech (BNTX) choose KPMG as its new independent auditor?
KPMG was selected after a comprehensive and competitive audit tender process overseen by BioNTech’s Audit Committee. The Audit Committee evaluated participating firms against predefined selection criteria and unanimously recommended KPMG to the Supervisory Board.
Why is BioNTech (BNTX) changing its external auditor if rotation is not mandatory?
BioNTech states it is not subject to mandatory auditor rotation requirements, but its Supervisory Board and Audit Committee believe periodically reassessing external audit arrangements through a competitive selection process is consistent with good governance practices.
When did BioNTech SE (BNTX) announce the proposed appointment of KPMG?
BioNTech announced the Supervisory Board’s approval of KPMG as independent auditor on September 18, 2026, noting that the appointment is for the financial year ending December 31, 2027 and is subject to shareholder election.
Who signed the BioNTech (BNTX) report announcing the new auditor?
The report was signed on behalf of BioNTech SE by Ramon Zapata-Gomez, Chief Financial Officer, and Dr. Sierk Poetting, Chief Operating Officer, dated September 18, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
